期刊文献+

控制性超促排卵患者卵泡液中SDF-1及VEGF水平测定及其与OHSS发病的相关性分析 被引量:5

The correlation between the concentration of SDF-1 and VEGF and the ovarian hyperstimulation syndrome
下载PDF
导出
摘要 目的:分析控制性超促排卵患者卵泡液中基质细胞衍生因子-1(SDF-1)和血管内皮生长因子(VEGF)的相关性,初步探讨SDF-1在卵巢过度刺激综合征(OHSS)发生中的作用。方法:选取因输卵管因素或男性因素行IVF/ICSI助孕治疗的72例患者。根据Golen标准分组:中、重度OHSS组26例(A组),无或轻度OHSS者46例(B组),ELISA法检测卵泡液中SDF-1、VEGF水平并进行相关性分析。结果:中、重度OHSS组的卵泡液SDF-1和VEGF水平为(3976.26±3150.92)pg/ml和(171.02±94.56)pg/ml,均显著高于无或轻度OHSS组[(1615.5±1542.68)和(126.23±86.32)pg/ml],差异有统计学意义(P=0.001,P=0.045)。中、重度OHSS组患者卵泡液中SDF-1与VEGF浓度和血清HCG日E2浓度有相关性(r=0.457,P=0.019;r=0.261,P=0.027)。结论:SDF-1可能参与或促进了OHSS的发生发展。 Objective: To investigate the action of SDF-1 on the ovarian hyperstimulation syndrome(OHSS) by analyzing the correlation between stromal cell-derived factor-1(SDF-1) and vascular endothelial growth factor(VEGF) in follicular fluid(FF).Methods:The levels of SDF-1 and VEGF in FF of 26 patients as Group A(moderate to severe OHSS)and 46 as Group B(mild or no OHSS; control group) undergoing IVF-ET/ICSI-ET were analyzed with Enzyme-linked immunoadsordent assay(ELISA).Results: The concentrations of SDF-1 and VEGF in Group A were(3976.26 ±3150.92) pg / ml,(171.02 ±94.56) pg / ml,significantly different from that in Group B [(1615.5 ± 1542.68) pg / ml,(126.23 ± 86.32) pg /ml](P = 0.001,P = 0.045).The correlation coefficients between SDF-1 and VEGF in Group A and B were 0.457 and 0.167(P = 0.019,P = 0.267),respectively.The correlation coefficient between the FF concentration of SDF-1 and serum concentration of estrogen was 0.261(P =0.027).Conclusion: The SDF-1 may promote the development of OHSS.
出处 《现代妇产科进展》 CSCD 北大核心 2016年第3期195-198,共4页 Progress in Obstetrics and Gynecology
关键词 基质细胞衍生因子 血管内皮生长因子 卵巢过度刺激综合征 体外受精-胚胎移植 Stromal cell-derived factor-1 Vascular endothelial growth factor Ovarian hyperstimulation syndrome In vitro fertilization-embryo transfer
  • 相关文献

参考文献15

  • 1Nastri CO,Ferriani RA,Rocha IA,et al.Ovarian hyperstimiilation syndrome:pathophysiology and prevention[J].J Assist Reprod Gen,2010,27(2/3):121-128.
  • 2Nishigaki A,Okada H,Okamoto R.Concentrations of stromal cell-derived factor-1 and vascular endothelial growth factor in relation to the diameter of human follicles[J].Fertil Steril,2011,95(2):742-746.
  • 3Nishigaki A,Okada H,Okamoto R.The concentration of human follicular fluid stromal cell-derived factor-1 is correlated with luteinization in follicles[J].Gynecol Endocrinol,2013,29(3):230-234.
  • 4Golan A,Ronel R,Herman A,et al.Ovarian hyperstimulation syndrome:an update review[J].Obstet Gynecol Surv,1989,44(6):430-440.
  • 5李兴,石庆之.基质细胞衍生因子-1及其受体、血管内皮生长因子与肿瘤血管生成的研究进展[J].新医学,2008,39(4):276-278. 被引量:1
  • 6Xueqing S,Guangcun Ch,Mingang H,et al.CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression[J].Cancer Metast Rev,2011,29(4):709-722.
  • 7Kryczek I,Frydman N,Gaudin F,et al.The chemokine SDF-1/CXCL12 contributes to T lymphocyte recruitment in human pre-ovulatory follicles and coordinates with lymphocytes to increase granulosa cell survival and embryo quality[J].Am J Reprod Immunol,2005,54(5):270-283.
  • 8Skinner MK,Schmidt M,Savenkova MI,et al.Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle developmen[J].Mol Reprod Dev,2008,75(9):1457-1472.
  • 9Sayasith K,Sirois J.Expression and regulation of stromal cell-derived factor-1(SDF1)and chemokine CXC motif receptor 4(CXCR4)in equine and bovine preovulatory follicles[J].Mol Cell Endocrinol,2014,391(1-2):10-21.
  • 10Bourdiec A,Bedard D,Rao CV,et al.Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation,migration and the release of angiogenic factors[J].Am J Reprod Immunol,2013,70(2):127-138.

二级参考文献27

  • 1李晟,陈子兴,王玮,岑建农,傅建新,姚利.CXCR4在急性白血病细胞中的表达及其对髓外浸润的意义[J].中华血液学杂志,2004,25(7):405-408. 被引量:15
  • 2寿成超.抗血管生成与肿瘤生物治疗[J].中国肿瘤生物治疗杂志,2006,13(6):401-403. 被引量:3
  • 3Aiuti A,et al.J Exp Med 1997,185:111 - 120.
  • 4Shegal A,et al.J Surg Oncol 1998,69(4): 239 - 248.
  • 5Muller A,et al.Nature 2001 ;410(6824): 50 - 56.
  • 6Murphy PM,et al.N Engl J Med 2001,345(11): 833-835.
  • 7Hatse S,et al.FEBS Lett 2002; 527 (1 - 3):255 - 262.
  • 8Hall JM,et al.Mol Endocrinol 2003,179(5): 792- 803.
  • 9Bachelder RE,et al.Cancer Res2002,62(24): 7203 - 7206.
  • 10Sloan EK,et al.CellMol Life Sci 2002,59(9): 1491 - 1502.

共引文献7

同被引文献48

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部